Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Summary:
- A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
| MarketCap | 62.5M |
|---|---|
| PE Ratio | -14.1 |
| PEG Ratio | -0.6 |
| P/B | 2.5 |
| P/S (ttm) | 2.6 |
| Earning Growth (QoQ) | |
| Revenue Growth (QoQ) | |
| Short % | 1% |
| Held by Institutions % | 73% |
| 1 Day Vol Adjusted Return | 0.0 |
| 1 Month Vol Adjusted Return | 2.6 |
| 3 Month Vol Adjusted Return | 3.4 |
| 6 Month Vol Adjusted Return | 3.4 |
| 20 Days SMA Price ZScore | -0.8 |
| 50 Days SMA Price ZScore | 0.3 |
| 12 -26 Days PPO | 3.1 |
| 1 Month Average Short Volume Ratio | 44.4 |
| 1 Day Volume Change ZScore | -0.7 |
| 1 Month Daily Vol | 5.9 |
Stock news
Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwide installed base increased by 23 placements in the fourth quarterHORSHAM, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products ...
HORSHAM, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the introduction of a new business, branded “Home by XTRAC™”. * Provides an at-home, insurance-reimbursed treatment option for patients with certain skin diseases that do not qualify for in-office treatm...
HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming H.C. Wainwright BioConnect Virtual Conference. Dates: Monday, January 11 to Thursday, January 14, 2021 Format: Presentation availabl...
HORSHAM, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it has renewed its existing debt with a lower interest one-year cash secured loan facility with Israel Discount Bank of New York, a multinational commercial bank. The new loa...
In this article we will check out the progression of hedge fund sentiment towards Strata Skin Sciences, Inc. (NASDAQ:SSKN) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 […]
Dolev Rafaeli has been the CEO of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) since 2018, and this article will examine...
Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results.Quarterly Results Earnings per share fell 33.33% year over year to ($0.04), which were in line with the estimate of ($0.04).Revenue of $5,613,000 decreased by 24.96% year over year, which beat the estimate of $4,900,000.Outlook Strata Skin Sciences hasn't issued any earnings guidance for the time being.Strata Skin Sciences hasn't issued any revenue guidance for the time being.How To Listen To T...
HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2020. Recent Highlights * Total revenue for the third quarter of 2020 was $5.6 million, a decrease of 25.0% over the third quarter of 2019 ...